Bibliographic citations
González, B., (2022). Comorbilidades en los pacientes fallecidos por Covid - 19 en el Hospital Santa Rosa de Piura durante el periodo 2020 - 2021 [Tesis, Universidad Privada Antenor Orrego. Facultad de Medicina Humana]. https://hdl.handle.net/20.500.12759/9299
González, B., Comorbilidades en los pacientes fallecidos por Covid - 19 en el Hospital Santa Rosa de Piura durante el periodo 2020 - 2021 [Tesis]. PE: Universidad Privada Antenor Orrego. Facultad de Medicina Humana; 2022. https://hdl.handle.net/20.500.12759/9299
@misc{renati/373633,
title = "Comorbilidades en los pacientes fallecidos por Covid - 19 en el Hospital Santa Rosa de Piura durante el periodo 2020 - 2021",
author = "González Guerra, Betty Alessandra",
publisher = "Universidad Privada Antenor Orrego. Facultad de Medicina Humana",
year = "2022"
}
To determine the relationship between the presence of comorbidities and mortality due to COVID-19. METHOD: An analytical, retrospective case-control study was conducted in hospitalized patients with a laboratory-confirmed diagnosis of COVID-19 at the Hospital de la Amistad Perú - Corea Santa Rosa in Piura, Peru. 4624 statistical records and medical records of patients from the years 2020-2021 were used. ICD X codes were regrouped into 22 codes, 10 corresponded to COVID 19 accompanied by other comorbidities and 12 to diseases or health situation that was accompanied by asymptomatic or sub-symptomatic COVID-19. RESULTS: The prevalence of comorbidities was 30.5% (1411), and had a significant statistical Chi-square association of 53,203, with a p-value of 0.00 (p<0.05), an OR of 1,604 (CI: 1,412; 1,823), The following were associated with a p<0. 05 the: chronic respiratory diseases (OR = 29.665, its CI: 3.957-22412), obesity (OR = 17.529, its CI: 6.275-48.968) infectious diseases (OR = 14.358, its CI: 7. 866 - 26.210), hematological diseases (OR = 12.199, its CI: 6.060-24.558), arterial hypertension (OR = 8.277, its CI: 5.823-11.764), acute and chronic renal failure (OR = 6.092 , its CI: 3. 362 - 11.038), diabetes mellitus (OR = 5.356, its CI: 3.832 - 7.487), cardiovascular pathology other than arterial hypertension, nor acute myocardial infarction (OR = 3.699, its CI: 1.605 - 8.525). Evaluating the association of the disease or health situation accompanied by COVID-19 and mortality, it was found that rheumatic diseases, urological diseases, benign tumors, dermatological pathology and renal pathology (without acute or chronic renal failure) were not related to mortality in hospitalized patients (p>0.05). Surgical pathologies, pregnancy, childbirth and puerperium; and trauma and fractures, present an OR < 1 (negative association). Additionally, mortality was found to be higher in the male sex ratio 2:1 and in those over 60 years of age. CONCLUSIONS: The presence of comorbidities is related to a higher probability of dying from COVID-19. In addition, age over 60 years and male sex were also associated with a higher probability of dying from COVID-19. For the analysis of mortality, it is important to differentiate COVID-19 with comorbidities from diseases or health situations that are accompanied by COVID-19.
This item is licensed under a Creative Commons License